Beauty and Skin Care

Bristol-Myers Squibb Co’s experimental skin cancer drug ipilimumab added an average of four months to the lives of patients with advanced melanoma, U.S. researchers said on Saturday, representing a major advance in a disease littered with drug failures.
Melanoma is one of the Read the rest of this entry »

Just as millions head to tanning beds to prepare for spring break, the Food and Drug Administration will be debating how to toughen warnings that those sunlamps pose a cancer risk.
Yes, sunburns are particularly dangerous. But there’s increasing scientific consensus that there’s Read the rest of this entry »